Reducing medication errors for hospital inpatients with Parkinsonism.
Parkinson disease
Parkinsonism
medication errors
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
revised:
24
01
2020
received:
24
10
2019
accepted:
27
01
2020
pubmed:
12
2
2020
medline:
1
6
2021
entrez:
12
2
2020
Statut:
ppublish
Résumé
Patients with Parkinsonism are 1.5 times more likely than comparators to be hospitalised and have a significantly longer length of stay in hospital. Medication delays, inappropriate medication omission, and administration of contraindicated medications likely contribute to these poor outcomes. Education and hospital system interventions may reduce these errors. To determine the effectiveness of a multimodal education and awareness campaign in reducing medication errors in patients with Parkinsonism at Hutt Hospital. We performed an audit of hospital medication charts to establish the baseline medication error rate and patient outcomes over a 3-month period. We then delivered an intervention consisting of staff education sessions, a sticker alert system and increased priority for pharmacist review of patient drug charts. We repeated the audit after the intervention. In the initial audit, the medication error rate was 22.5%, the clinical complication rate was 45% and one death was directly attributable to medication error. At follow up, the medication error and complication rates were 9.3% (absolute difference 13% (95% conflict of interest (CI) 10-16.4), P < 0.001) and 38% (absolute difference 7% (95% CI -19 to 34), P = 0.59), respectively, and there were no attributable deaths. The average length of stay before and after the intervention was 13 and 8 days respectively (absolute difference 5.7 days (95% CI -1.8 to 13.3), P = 0.135). There was a high in-hospital medication error rate for Parkinsonian patients. The intervention resulted in a statistically significantly improvement in the medication error rate. The estimated reductions in complication rate and length of stay may be clinically important. Similar interventions may be beneficial in other institutions.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with Parkinsonism are 1.5 times more likely than comparators to be hospitalised and have a significantly longer length of stay in hospital. Medication delays, inappropriate medication omission, and administration of contraindicated medications likely contribute to these poor outcomes. Education and hospital system interventions may reduce these errors.
AIM
OBJECTIVE
To determine the effectiveness of a multimodal education and awareness campaign in reducing medication errors in patients with Parkinsonism at Hutt Hospital.
METHODS
METHODS
We performed an audit of hospital medication charts to establish the baseline medication error rate and patient outcomes over a 3-month period. We then delivered an intervention consisting of staff education sessions, a sticker alert system and increased priority for pharmacist review of patient drug charts. We repeated the audit after the intervention.
RESULTS
RESULTS
In the initial audit, the medication error rate was 22.5%, the clinical complication rate was 45% and one death was directly attributable to medication error. At follow up, the medication error and complication rates were 9.3% (absolute difference 13% (95% conflict of interest (CI) 10-16.4), P < 0.001) and 38% (absolute difference 7% (95% CI -19 to 34), P = 0.59), respectively, and there were no attributable deaths. The average length of stay before and after the intervention was 13 and 8 days respectively (absolute difference 5.7 days (95% CI -1.8 to 13.3), P = 0.135).
CONCLUSIONS
CONCLUSIONS
There was a high in-hospital medication error rate for Parkinsonian patients. The intervention resulted in a statistically significantly improvement in the medication error rate. The estimated reductions in complication rate and length of stay may be clinically important. Similar interventions may be beneficial in other institutions.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
385-389Informations de copyright
© 2020 Royal Australasian College of Physicians.
Références
Pringsheim T, Jette N, Frolkis A, Steeves T. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2014; 29: 1583-90.
Gerlach O, Winogrodzka A, Weber W. Clinical problems in the hospitalized Parkinson's disease patient: systematic review. Mov Disord 2011; 26: 197-208.
Gerlach O, Broen MP, Van Domburg PH, Vermeij AJ, Weber WE. Deterioration of Parkinson's disease during hospitalization: survey of 684 patients. BMC Neurol 2012; 12: 13.
Lertxundi U, Isla A, Solinís MÁ, Domingo-Echaburu S, Hernandez R, Peral-Aguirregoitia J et al. Medication errors in Parkinson's disease patients in the Basque Country. Parkinsonism Relat Disord 2017; 36: 57-62.
Gerlach O, Broen M, Weber W. Motor outcomes during hospitalization in Parkinson's disease patients: a prospective study. Parkinsonism Relat Disord 2013; 19: 737-41.
Buetow S, Henshaw J, Bryant L, O'Sullivan D. Medication timing errors for Parkinson's disease: perspectives held by caregivers and people with Parkinson's in New Zealand. Parkinsons Dis 2010; 2010: 1-6.
Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R et al. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord 2011; 17: 139-45.
Parkinson's UK. “Get It on Time” campaign. [cited 2019 Jul 5]. Available from URL: www.parkinsons.org.uk
Muzerengi A, Herd C, Rick C, Clarke CE. A systematic review of interventions to reduce hospitalisation in Parkinson's disease. Parkinsonism Relat Disord 2016; 24: 3-7.
Hou JG, Wu LJ, Moore S, Ward C, York M, Atassi F et al. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord 2012; 18: 377-81.